Table 2 Correlation between hsa_circ_000200 expression and clinical pathological characteristic in GC (n = 95)
Features | Number | High | Low | P value |
|---|---|---|---|---|
Gender | ||||
Male | 68 (72%) | 57 (72%) | 11 (69%) | 0.768 |
Female | 27 (28%) | 22 (28%) | 5 (31%) | |
Age (years) | ||||
< 60 | 19 (20%) | 15 (19%) | 4 (25%) | 0.732 |
≥ 60 | 76 (80%) | 64 (81%) | 12 (75%) | |
Tumor size (cm) | ||||
< 5 | 43 (45%) | 33 (42%) | 10 (63%) | 0.171 |
≥ 5 | 52 (55%) | 46 (58%) | 6 (37%) | |
Lymphatic metastasis | ||||
N0 | 20 (21%) | 15 (19%) | 5 (31%) | 0.316 |
N1–3 | 75 (79%) | 64 (81%) | 11 (69%) | |
Distal metastasis | ||||
M0 | 93 (98%) | 77 (97%) | 16 (100%) | 0.988 |
M1 | 2 (2%) | 2 (3%) | 0 (0%) | |
Invasion depth | ||||
T1 and T2 | 5 (5%) | 1 (1%) | 4 (25%) | 0.003** |
T3 and T4 | 90 (95%) | 78 (99%) | 12 (75%) | |
TNM stage | ||||
I and II | 20 (21%) | 13 (16%) | 7 (44%) | 0.038* |
III and IV | 75 (79%) | 66 (84%) | 9 (56%) | |